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Introduction: Nuclear accumulation of a mutant form of the nuclear protein Lamin-A, called Progerin (PG) or Lamin
AΔ50, occurs in Hutchinson-Gilford Progeria Syndrome (HGPS) or Progeria, an accelerated aging disease. One of the
main symptoms of this genetic disorder is a loss of sub-cutaneous fat due to a dramatic lipodystrophy.
Methods: We stably induced the expression of human PG and GFP -Green Fluorescent Protein- as control in 3T3L1
cells using a lentiviral system to study the effect of PG expression in the differentiation capacity of this cell line, one
of the most used adipogenic models. Quantitative proteomics (iTRAQ) was done to study the effect of the PG
accumulation. Several of the modulated proteins were validated by immunoblotting and real-time PCR. Mitochondrial
function was analyzed by measurement of a) the mitochondrial basal activity, b) the superoxide anion production and
c) the individual efficiency of the different complex of the respiratory chain.
Results: We found that over-expression PG by lentiviral gene delivery leads to a decrease in the proliferation rate and
to defects in adipogenic capacity when compared to the control. Quantitative proteomics analysis showed 181 proteins
significantly (p < 0.05) modulated in PG-expressing preadipocytes. Mitochondrial function is impaired in PG-expressing
cells. Specifically, we have detected an increase in the activity of the complex I and an overproduction of Superoxide
anion. Incubation with Reactive Oxygen Species (ROS) scavenger agents drives to a decrease in autophagic proteolysis
as revealed by LC3-II/LC3-I ratio.
Conclusion: PG expression in 3T3L1 cells promotes changes in several Biological Processes, including structure of
cytoskeleton, lipid metabolism, calcium regulation, translation, protein folding and energy generation by the
mitochondria. Our data strengthen the contribution of ROS accumulation to the premature aging phenotype and
establish a link between mitochondrial dysfunction and loss of proteostasis in HGPS.* Correspondence: fblagar@sergas.es; maria.arufe@udc.es
†Equal contributors
1Grupo de Proteómica-ProteoRed/Plataforma PBR2-ISCIII, Servicio de
Reumatología, Instituto de Investigación Biomédica de A Coruña (INIBIC),
Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas,
Universidade da Coruña, As Xubias, 15006 A Coruña, Spain
2Cellular Therapy and Medicine Regenerative Group, Department of
Medicine, Instituto de Investigación Biomédica de A Coruña (INIBIC),
Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas,
Universidade da Coruña, As Xubias, 15006 A Coruña, Spain
Full list of author information is available at the end of the article
© 2015 Mateos et al. This is an Open Access a
(http://creativecommons.org/licenses/by/4.0),
provided the original work is properly credited
creativecommons.org/publicdomain/zero/1.0/rticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Mateos et al. Stem Cell Research & Therapy  (2015) 6:119 Page 2 of 17Introduction
Mutations in the LMNA gene are the causal agent for a
subset of genetic diseases affecting mesoderm tissues
called laminopathies [1]. Among these, Hutchinson-
Gilford Progeria Syndrome (HGPS) or progeria [2–4]
is a fatal disease with a very low incidence character-
ized by a typical clinical picture of older pathologies
[5]. HGPS-affected patients begin to show symptoms
of accelerated aging at the age of 2, and typically die at
an average age of 13 years, usually due to cardiovascu-
lar deficiencies. HGPS is due, in most cases, to the
point mutation G608G in the LMNA gene encoding
Lamins A and C, major structural components of the
nuclear lamina [6, 7]. Although historically thought to
be involved only in nuclear structure, roles in replica-
tion, chromatin organization and stem cell differenti-
ation have been demonstrated recently for Lamin A
[8, 9]. It is also proposed that Lamin A has a role in
reorganization of replication and chromatin [10].
Lamin A is initially produced as a precursor, pre-
Lamin A, farnesylated at its C-terminus, and processed
by the protease Zmpste24/FACE-1 that removes the
farnesylated part. In HGPS, the mutation causes the
occurrence of a cryptic alternative processing site, gen-
erating a truncated isoform, progerin (PG), lacking the
recognition site for Zmpste24/FACE-1. Farnesylated
PG does not properly process, accumulates in the nu-
clear envelope, causes structural defects in the nuclear
lamina and may be interfering with regulation of the
signalling pathway mediated by p16/Rb necessary to
maintain the balance between differentiation and pro-
liferation of stem cells in the tissue regeneration
process [8]. Finally, several studies showed the import-
ance of accumulation of the farnesylated precursor in
the development of the disease [11–13].
The main function of adipose tissue is to store and man-
age excess energy in the form of triglycerides and to facili-
tate the liberation and lipolysis in periods of nutritional
deficiency or energy demand [14]. The balance between
lipid storage and lipolysis is controlled by neuroendocrine
signals [15, 16] in response to the nutritional status of the
organism. The hypothalamus has been proposed as the
central coordinator of this process, integrating the action of
circulating hormones and nutrients [17]. In human lipody-
strophies, insulin resistance and loss of regenerative poten-
tial in the adipose tissue are the main landmarks [18]
leading to complications in normal aging and disease. Also,
an extremely accelerated lipodystrophia occurs in proger-
oid syndromes, such as HGPS and other laminopathies
[19, 20].
Our purpose for this study was to unravel the underlying
mechanism of PG-driven lipodystrophy using quantitative
shotgun proteomics (isobaric tags for relative quantification
(iTRAQ)) and to determine the molecular pathwaysmodulated by the lentiviral expression of this aberrant form
of Lamin A in the 3T3L1 pre-adipocyte cell line, one of the
most studied models of adipogenic differentiation [21, 22].
Methods
Culture of mouse 3T3L1 pre-adipocytes
3T3L1 cells were kindly donated by María Pardo and
Luisa M Seoane (University of Santiago, Spain). Cells were
maintained as pre-adipocytes in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10 % foetal
bovine serum (FBS) and expanded when they reached
70 % confluence.
Cloning procedure
Full-length human PG and green fluorescent protein
(GFP) cDNAs were amplified by PCR from pBABE-
puroGFP-PG and pBABE-puroGFP-Lamin A plasmids
(Addgene, donated by Tom Misteli), using the oligonu-
cleotides: EcoRI-LMNA-forward, CCGGAATTCATGG
AGACCCCGTCCCAGCGG; BamHI-LMNA-reverse, CG
CGGATCCTTACATGATGCTGCAGTTCTG; EcoRI-GF
P-forward, CCGGAATTCATGGTGAGCAAGGGCGAG;
and BamHI-GFP-reverse, CGCGGATCCTTACTTGTAC
ACCTCGTC. GFP, LMNA and PG were cloned into
pLVX-puro (Clontech Laboratories Inc., Mountain View,
CA, USA) between the EcoRI/BamHI sites following
standard cloning procedures.
Lentiviral production
The Lenti-X™ Lentiviral expression System (Clontech
Laboratories Inc.) was used following the manufacturer’s
protocol. One day before transfection, 4 × 106 293 T
producer cells were plate on 100 mm plates in penicil-
lin/streptomycin-free DMEM supplemented with 5 %
FBS. The following day, two different calcium-phosphate
based transfections were performed in duplicate using
LVX-GFP-puro and LVX-PG-puro. The cells were incu-
bated overnight with the transfection mixture, then
washed with phosphate-buffered saline (PBS) and incu-
bated with 8 ml fresh complete growth medium.
Viral supernatants were collected at 48, 60 and 72 hours
following transfection, centrifuged, filtered to remove cell
debris and stored at 4 °C until transduction.
Transduction of 3T3L1 cells
Target cells were plated in 100 mm plates at 6 × 106
cells per plate. After 1 day, the cells were 70 % conflu-
ent. The cells were incubated sequentially with the
48-hour, 60-hour and 72-hour viral supernatants for
12 hours. Following the last transduction, the cells were
washed and incubated with fresh growth medium to
allow puromycin-resistance expression. Two days later,
puromycin selection was performed by incubating the
cells in growth media supplemented with 1 μg/ml
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selection, transduced cells were washed and allowed to
recover in complete media for 2 days.
Proliferation assay
To calculate the proliferation curve, different numbers
of cells (0, 1000, 2000, 4000, 8000 and 16,000) were
plated in triplicate in 96-well plates and allowed to
adhere for 8 hours. The CellTiter 96® AQueous Non-
Radioactive Cell Proliferation Assay (Promega, Madison,
WI, USA) was used to measure absorbance at 490 due
to the formation of MTS formazan. For the assay, 2000
cells were plated in triplicate in 96-well plates, and the
total cell number was calculated at different time points
(2, 4, 6 and 10 days) by extrapolating the correspondent
absorbance in the proliferation curve.
Adipogenic differentiation
Untransduced and PG-transduced and GFP-transduced
3T3L1 pre-adipocytes were differentiated in DMEM
supplemented with 10 % FBS in chamber slides
(Millipore, Billerica, MA, USA). Two days after reaching
confluence, the medium was supplemented with 10 μg/
ml insulin, 0.5 mM of 3-isobutyl-1-methylxantine and
1 am dexamethasone for 3 days and with 5 μg/ml insulin
for a further 6 days.
Adipogenic cultures were stained with Oil red O to
determine their adipogenic capacity. For staining, the
culture plates were fixed in 10 mM sodium periodate, 2 %
paraformaldehyde, 75 mML-lysine dihydrochloride and
37.5 mM dibasic sodium phosphate (Sigma-Aldrich, St.
Louis, MO, USA) at pH 7.4 for 15 minutes at room
temperature, then air dried and treated with a filtered solu-
tion of 0.3 % Oil red O to stain lipid droplets.
Protein extraction and preparation procedures
Cells monolayers were grown until a confluence of 70 % in
100 mm plates, and then washed three times with PBS and
harvested with a scraper in SDS lysis buffer (20 % glycerol,
500 mM Tris–HCl, pH 6.8 and 10 % sodium dodecyl
sulphate). After incubation at 100 °C for 10 minutes and
two consecutive cycles of vortexing and sonication, sam-
ples were centrifuged at 4 °C for 10 minutes at 11000 × g.
Supernatants were then subjected to protein quantifica-
tion (total protein A 280) in a nanodrop™ 1000 instrument
(Thermo Scientific, Waltham, MA, USA). Protein extracts
were aliquoted and stored at −80 °C until further analysis.
iTRAQ labelling
Equal amounts of proteins from PG-3T3L1 and GFP-
3T3L1 cells (50 μg) were precipitated with overnight
incubation with six volumes of cold acetone at −20 °C,
and denatured with 2 % sodium dodecyl sulphate in 1 Mtriethylammonium bicarbonate (ABSciex, Foster City,
CA, USA). The samples were then reduced for 1 hour at
60 °C using 50 mM tris-(2-carboxyethy) phosphine
(ABSciex), and cysteine-blocked with 84 mM iodoaceta-
mide (Sigma-Aldrich) at room temperature in the dark for
30 minutes. The injection volumeThe proteins were
digested with spectrometry-grade trypsin (Gold Mass,
Promega, Madison, WI, USA) at a concentration of 1:50
trypsin/protein for 16 hours at 37 °C. Each peptide solution
was labelled for 1.5 hours at room temperature using the
iTRAQ reagents (ABSciex) previously reconstituted in
70 μl ethanol, following the manufacturer’s protocol. The
samples were labelled with iTRAQ reagents as follows: con-
trol GFP, 115; PG: 117. The reaction was stopped by adding
deionized water, and the labelled samples were combined.
The mixture was desalted using homemade stage tips.
iTRAQ relative quantification by two-dimensional LC-
MALDI-TOF/TOF analysis
In a first step, the desalted peptides (starting amount
of digested peptides: 100 μg) were fractionated by basic
reversed-phase extraction in a 1200 HPLC system
(Agilent, Wilmington, DE, USA). Sixty fractions, each
representing a 90-second elution, were collected along
a 110-minute gradient. The fractions were combined in
16 different final fractions depending on their peptide
complexity (as revealed by lecture absorbance at
214 nm during the basic reversed-phase separation).
The combined fractions were subjected to further
acidic reversed-phase extraction in a nanoHPLC sys-
tem (Tempo; ABSciex) into a C18 silica-based column
(New Objective, Woburn, MA, USA) with an internal
diameter of 300 Ả. The injection volume was 5 μl, and
peptides were eluted during a 90-minute gradient at a
constant flow rate of 0.35 μl/minute. Eluting peptides
were automatically mixed with alpha-cyano at 4 mg/ml
in 70 % acetonitrile, 0.1 % trifluoroacetic acid and de-
posited on a MALDI LC-plate using a SunCollect
(SunChrom, Friedrichsdorf,GE) spotter. The 16 differ-
ent chromatograms, each composed of 350 spots
(15 seconds deposition per spot), were then analysed in
a 4800 MALDI-TOF/TOF platform (ABSciex). The
4000 series Explorer v.4.2 software was used to gener-
ate the spectra and peak list. After manual deposition
of mass calibrants, plate model and default calibration
of the MALDI plate was carried out with a laser voltage
of 3200 kV and 1000 shots/spectrum. Samples were
automatically analysed in MS mode with a laser voltage
of 3400 kV and 1500 shots/spectrum.
Automated precursor selection was performed using
a Job-wide interpretation method (up to 12 precur-
sors/fraction, signal-to-noise lower threshold = 50) ex-
cluding trypsin autolytic peptides and other
background ions, with a laser voltage of 4200 and
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ation (CID) energy range was medium.
Liquid chromatography coupled offline to matrix-
assisted laser desorption ionization–time of flight (LC-
MALDI-TOF/TOF) data were analysed using Protein-
Pilot 4.0 software (ABSciex). ProteinPilot search pa-
rameters were as follows: sample type, iTRAQ 4-plex;
cys-alkylation, iodoacetamide; digestion, trypsin; ID
focus, biological modifications; database, NCBI
RefSeq-release60 (September 2013) with 41,958,567
entries; species filtering, none; search effort, thorough
ID and Detection Protein Threshold Unused Prot-
Score (Conf ) > 1.3 (95.0 %). The scoring model was
defined by the Paragon algorithm. In the case of the
high-complexity samples, the false discovery rate was
estimated in less than 1 % by doing the searching in
parallel against a decoy database using the ‘PSPEP on’
mode (data not shown).
Bioinformatics
Biological functional analysis of the different modulated
proteins detected by iTRAQ quantification was catego-
rized according to their function, biological process and
cellular component, using the String 9.0 software [23].
Measurement of the production of mitochondrial reactive
oxygen species
Cells were cultivated in six-well plates in DMEM with 10 %
FBS until reaching 70 % confluence, and then washed and
incubated for 1 hour with serum-free DMEM. Incubation
with 5 μMMitoSox™ (Invitrogen) was done for 10 minutes
at 37 °C following the manufacturer’s instructions. Mito-
chondrial reactive oxygen species (ROS) production was
estimated by flow cytometry in a FACSAria instrument
(Benton Dickinson, Oxford, UK). The percentage of posi-
tive cells was measured for each condition by fluorescent
emission at 580 nm.
Measurement of the mitochondrial reespiratory chain
complex activities
For each condition 10 × 106 cells were collected by tryp-
sinization, washed with PBS, and precipitated at 150 × g
for 5 minutes at 4 °C. Digitonin-permeabilized pre-
adipocyte homogenates (10–50 μl/ml test volume) were
used to measure the activities of the respiratory chain
enzymes and citrate synthase in a DU-650 spectropho-
tometer (Beckman Instruments, Palo Alto, CA, USA) as
described previously [24, 25].
Determination of basal mitochondrial respiration
The rate of oxygen consumption (OCR) was determined
by direct measurement in a SeaHorse XFp Extracellular
Flux Analyzer instrument (Seahorse Bioscience Inc.,
Billerica, MA, USA). Then 104 cells per well were seeded24 hours prior to the assay in XF cell culture microplates
and incubated at 37 °C with 5 % CO2. The next day, the
cells were pre-incubated without CO2 for 1 hour and the
basal OCR was determined following the manufacturer’s
instructions.
Immunoblotting procedures
Western blot analysis was performed on 20 μg total pro-
tein extracted from cells in culture, as described previ-
ously [26]. The antibodies used were mouse Lamin A +
C (Acris Antibodies, Acris Antibodies, Barcelone,ES),
rabbit calnexin (Santa Cruz Biotech., Santa Cruz, CA,
USA), rabbit nucleolin (NCL; Santa Cruz Biotech.),
rabbit cytochrome c oxidase (Amersham, Buckingham-
shire, UK), rabbit microtubule-associated protein 1 light
chain 3 (LC3; MBL, Nagoya, Japan) and mouse tubulin
(Sigma). Ideal concentrations for each antibody were de-
termined empirically. Working concentrations were
1:1000 of the stock solutions. Secondary anti-mouse
and anti-rabbit antibodies (Amersham) were used to
visualize proteins by the ECL™ Western Blotting Ana-
lysis System (GE Healthcare, Amersham Biotechnology,
Buckinghamshire, UK). Optimal concentrations for
each antibody were determined empirically. Blots were
digitized using the LAS 3000 image analyser (GE
Healthcare). Densitometry analysis of the band inten-
sities was performed using ImageQuant 5.2 software
(GE Healthcare).
RNA extraction and cDNA synthesis
Total RNA was extracted from cultured cells seeded in
six-well plates at a confluence of 70 % using the Trizol
L.S. reagent method (Invitrogen). Reverse transcription
was done using the Superscript II system (Invitrogen).
Then 2 μg total RNA was reverse transcribed in a 20 μl
reaction volume containing Superscript II (200 Units),
random primers (25 μM) and dNTP (0.5 mM each) at
42 °C for 50 minutes.
Real-time RT-PCR analysis
The reported sequences of genes for mouse Lmna (for-
ward, TGAGTACAACCTGCGCTCAC; reverse, CTGT
GACACTGGAGGGCAGAA), mouse Ncl (forward, AA
GGAGTGAAGCCAGCAAAA; reverse, TCCTCCTCAG
CCACACTCTT), mouse Canx (forward, GCCCTAGAG
ACTGCTCCAT; reverse, AAAAAGCCTTGTGCTCCA
CA), mouse Cox5a (forward, GGAATTGCGTAAAGGG
ATGA; reverse, CCAAGATGCGAAGACCACTA) and
mouse Hprt (forward, TCCCAGCGTCGTGATTAGCG
A; reverse, TGGCCTCCCATCTCCTTCATGAC), as
housekeeping, were used for primer design. The amplifi-
cation program consisted of an initial denaturation at
92 °C for 2 minutes followed by 40 cycles at 92 °C for
15 seconds, annealing at 61 °C for 30 seconds and an
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was done in duplicate, with each set of assays repeated
three times. To minimize effects of unequal quantities of
starting RNA and to eliminate potential sources of in-
consistency, relative expression levels of each gene were
normalized to Hprt using the 2–ΔΔCt method [27]. Con-
trol experiments contained no reverse transcriptase.Statistical analysis
All of the experimental data, with the exception of the
iTRAQ relative quantification, are presented as the
mean, and error bars represent the standard deviation of
the mean. Statistical analysis was carried out with R 3.0
(Project for Statistical Computing) using non-parametric
methods.Fig. 1 Characterization of green fluorescent protein (GFP)-expressing and p
GFP was corroborated by immunoblot and fluorescence microscopy, resp
compared with GFP-3T3L1 and non-transduced cells. c Defective adipoge
non-transduced cells, as revealed by Oil-red staining. *Significance (p <0.Results
Gene delivery by lentiviral transduction and
characterization of cell lines
Efficient gene delivery of PG was checked by immunoblot-
ting using an anti-LMNA/C antibody. As shown in Fig. 1a,
PG-lentiviral transduction of 3T3L1 pre-adipocytes drives
the production of an intermediate molecular weight
isoform with a similar size as human PG, as well as an
abnormal accumulation of wild-type Lamin A as
described previously [28, 29]. The efficiency of the
transduction was estimated in more than 80 % by
fluorescence microscopy. Proliferation capacity was
checked in the three cell lines, showing a significant
decrease (p <0.05) in the proliferation rate of PG-
3T3L1 cells when compared with non-transduced and
control GFP-3T3L1 cells. Adipogenic capacity of therogerin (PG)-expressing 3T3L1 cells. a Efficient gene delivery of PG and
ectively. b Decrease in the proliferation rate of PG-3T3L1 cells when
nic potential of PG-3T3L1 cells when compared with GFP-3T3L1 and
05) using the Kruskal–Wallis non-parametric test. Scale bar = 20 μm
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pogenic medium for 7 days followed by Oil red staining
and haematoxylin and eosin counterstaining (Fig. 1c).
PG-3T3L1 cells show a defective adipogenic capacity
when compared with non-transduced and control
GFP-3T3L1 cells. Oil red densitometry demonstrates a
significant (p <0.05) decrease in the total area of the
lipid droplets (Fig. 1c).Fig. 2 Isobaric tags for relative quantification (iTRAQ) of modulated protein
of modulated proteins in PG-3T3L1 cells. b Summary of the protein identifi
processes after String 9.0 analysis of the modulated individual proteins. GFP
chromatography coupled offline to matrix-assisted laser desorption ionizatiiTRAQ relative quantification
A summary of the workflow followed for iTRAQ relative
quantification of modulated proteins in PG-3T3L1 cells
versus GFP-3T3L1 cells is shown in Fig. 2a. A total of
1633 proteins were identified after grouping; 76 of them
were significantly decreased whereas 105 were increased
in PG-3T3L1 versus control (Fig. 2b). Proteins were con-
sidered significantly modulated if the 117/115 ratio wass in 3T3L1-PG cells. a Workflow followed for the relative quantification
cation and relative quantification. c Significantly modulated biological
green fluorescent protein, GO gene ontology, LC-MALDI-TOF liquid
on–time of flight, PG progerin
Table 1 Modulated proteins (p <0.05) in PG-3T3L1 cells classified according to their principal biological process
Accession
number
Name Total number of
peptides
iTRAQ 1 ratio PG/
control
iTRAQ 2 ratio PG/
control
Actin cytoskeleton organization
gi|157951604 Adenylyl cyclase-associated protein 1 9 1.80 1.81
gi|6680924 cofilin-1 22 2.63 2.63
gi|6681069 Cysteine and glycine-rich protein 1 9 0.41 0.44
gi|62526118 Cytoskeleton-associated protein 4 22 6.02 5.81
gi|125347376 Filamin-A 123 0.06 0.06
gi|145966915 Filamin-B 89 0.18 0.22
gi|124487139 Filamin-C 51 0.42 0.44
gi|130488506 Four and a half LIM domains protein 3 8 0.39 0.34
gi|61657921 Kinesin-1 heavy chain 14 0.49 0.44
gi|6755040 Profilin-1 19 2.90 2.94
gi|10946578 Thymosin beta-4 15 0.42 0.44
gi|47894398 Tropomyosin alpha-4 chain 51 0.57 0.60
gi|31982755 Vimentin 101 27.8 29.5
Alternative splicing
gi|85060507 Heterogeneous nuclear ribonucleoprotein A1 27 6.94 8.24
gi|21313308 Heterogeneous nuclear ribonucleoprotein M 17 2.70 2.85
gi|283436178 Heterogeneous nuclear ribonucleoproteins C1/C2 10 1.82 1.85
gi|6678143 Lupus La protein homolog 9 1.57 1.89
gi|31560656 Polyadenylate-binding protein 1 24 1.55 1.88
gi|126157504 Serine/arginine repetitive matrix protein 2 12 0.33 0.35
gi|34328400 Serine/arginine-rich splicing factor 1 isoform 1 12 0.58 0.63
gi|153791358 Splicing factor 3B subunit 1 7 0.50 0.52
gi|268837785 Splicing factor 3b, subunit 2 16 1.59 1.62
gi|23956214 Splicing factor, proline- and glutamine-rich 22 1.48 1.45
ATP metabolism
gi|6680748 ATP synthase subunit alpha 21 2.53 2.48
gi|31980648 ATP synthase subunit beta 32 5.89 5,84
gi|7949005 ATP synthase-coupling factor 6 8 0.35 0.38
gi|150456419 ATP-dependent RNA helicase A 10 0.52 0.45
gi|134288917 Cytoplasmic dynein 1 heavy chain 1 16 0.48 0.53
Calcium-mediated signalling
gi|6996913 Annexin A2 28 1.89 1.72
gi|6753060 Annexin A5 26 6.01 6.47
gi|21704156 Caldesmon 1 31 2.17 2.49
gi|6753244 Calmodulin 22 0.31 0.31
gi|6671664 Calnexin 14 1.62 2.44
gi|21312564 Calponin-3 15 2.01 1.79
gi|6680836 Calreticulin precursor 31 3.37 3,98
gi|31981086 EF-hand domain-containing protein D2 6 0.39 0.40
gi|6679465 Glucosidase 2 subunit beta precursor 9 0.59 0.69
gi|33620739 Myosin light polypeptide 6 24 0.69 0.39
gi|6677833 Protein S100-A10 11 0.28 0.31
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Table 1 Modulated proteins (p <0.05) in PG-3T3L1 cells classified according to their principal biological process (Continued)
gi|6677691 Reticulocalbin-1 precursor 10 0.50 0.69
gi|114205428 Reticulocalbin-2 precursor 12 0.48 0.45
gi|188035858 Reticulocalbin-3 precursor 13 0.41 0.54
gi|295054266 Spectrin alpha chain, brain isoform 2 80 0.60 0.58
gi|117938332 Spectrin beta chain, brain 1 isoform 1 45 0.50 0.43
Cell adhesion
gi|61743961 AHNAK nucleoprotein isoform 1 265 0.63 0.62
gi|6754508 LIM and SH3 domain protein 1 15 0.55 0.59
gi|225543161 Lipoma-preferred partner homolog isoform 1 18 0.55 0.55
gi|70778915 Moesin 41 3.31 2.80
gi|33598964 Myosin-10 42 0.18 0.19
gi|114326446 Myosin-9 isoform 1 127 0.05 0.04
gi|254675244 Plectin isoform 1 151 0.31 0.56
gi|377835925 Protein AHNAK2-like 16 0.78 0.54
gi|227116327 Talin-1 42 0.25 0.24
gi|6678347 Thy-1 membrane glycoprotein preproprotein 5 4.15 3.93
gi|6756085 Zyxin 19 0.52 0.55
gi|114326497 Laminin subunit beta-1 5 0.34 0.37
gi|31982030 Rho GDP-dissociation inhibitor 1 10 2.60 2.49
DNA replication
gi|6679299 Prohibitin 9 1.82 2.39
gi|7242171 Proliferating cell nuclear antigen 10 1.73 1.78
Extracellular matrix organization
gi|34328108 Collagen alpha-1(I) chain precursor 56 0.66 0.49
gi|111120329 Collagen alpha-2(I) chain precursor 53 0.67 0.68
gi|33859580 Galectin-3 12 1.96 1.81
gi|33859596 Prolyl 4-hydroxylase subunit alpha-1 precursor 14 1.89 1.89
Glycolysis
gi|6679937 Glyceraldehyde-3-phosphate dehydrogenase 33 25.5 23.1
gi|70778976 Phosphoglycerate kinase 1 40 3.37 3.18
gi|226958349 Triosephosphate isomerase 20 2.58 2.53
gi|70794816 Alpha enolase 55 16.8 20.2
Golgi apparatus function
gi|254750698 Nucleobindin-1 isoform 1 precursor 17 0.53 0.54
gi|194440700 Nucleobindin-2 isoform 1 precursor 5 0.53 0.54
Lipid metabolism
gi|6681137 Acyl-CoA-binding protein isoform 2 10 0.29 0.29
gi|63999380 Alpha-2-macroglobulin receptor-associated 4 0.40 0.42
gi|313151222 ATP-citrate synthase isoform 1 10 0.46 0.53
gi|93102409 Fatty acid synthase 8 0.55 0.55
gi|225735657 Sulphated glycoprotein 1 isoform F preproprotein 9 5.49 5.24
Lipid transport
gi|19527028 Vigilin 15 1.52 1.47
gi|38198665 NSFL1 cofactor p47 13 0.69 0.64
Nuclear structure
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Table 1 Modulated proteins (p <0.05) in PG-3T3L1 cells classified according to their principal biological process (Continued)
gi|162287370 Prelamin-A/C isoform A 47 4.62 4.79
gi|7110705 Prothymosin alpha 7 0.42 0.43
Nucleosome assembly
gi|7949045 Histone H2A.Z 6 1.73 1.49
gi|13591862 Protein SET isoform 1 21 0.22 0.27
Nucleotide biosynthesis
gi|209862992 Dihydropyrimidinase-related protein 3 isoform 1 18 1.95 1.75
gi|377835587 inosine-5′-monophosphate dehydrogenase 2-like 9 1.47 1.68
Oxidation–reduction process
gi|31542438 Cytochrome b5 type B precursor 6 3.05 3.20
gi|112181182 Cytochrome c oxidase subunit 5A 12 0.35 0.28
gi|6681095 Cytochrome c, somatic 9 0.44 0.41
gi|112293264 Protein disulphide-isomerase A3 precursor 49 6.03 5.80
gi|86198316 Protein disulphide-isomerase A4 precursor 27 1.55 1.61
gi|42415475 Protein disulphide-isomerase precursor 44 1.86 1.87
gi|6755911 Thioredoxin 10 0.47 0.47
Protein catabolic process
gi|6679501 26S protease regulatory subunit 4 15 2.21 2.59
gi|228008337 26S protease regulatory subunit 6A 16 1.97 1.93
gi|124248577 26S protease regulatory subunit 6B 12 2.27 2.37
gi|19882201 26S proteasome non-ATPase regulatory subunit 9 0.54 0.52
gi|6755212 Proteasome activator complex subunit 1 12 0.60 0.58
Protein folding and stress response
gi|6680309 10 kDa heat shock protein, mitochondrial 8 0.34 0.34
gi|183396771 60 kDa heat shock protein, mitochondrial 46 23.9 13.9
gi|115270960 BAG family molecular chaperone regulator 3 9 0.57 0.59
gi|6755863 Endoplasmin precursor 42 6.42 7.51
gi|31981690 Heat shock cognate 71 kDa protein 68 14.4 19.9
gi|6754254 Heat shock protein HSP 90-alpha 44 2.22 2.26
gi|40556608 Heat shock protein HSP 90-beta 48 2.55 2.46
gi|27229055 Huntingtin-interacting protein K 5 0.40 0.42
gi|161353506 Serpin H1 precursor 22 2.44 2.39
gi|162461907 Stress-70 protein, mitochondrial 52 2.05 2.04
gi|126521835 T-complex protein 1 subunit beta 18 1.71 1.68
gi|6671702 T-complex protein 1 subunit epsilon 16 1.59 1.51
gi|6753324 T-complex protein 1 subunit zeta 11 1.66 1.75
Protein transport
gi|28077049 Charged multivesicular body protein 4b 9 0.51 0.51
gi|51491845 Clathrin heavy chain 1 18 0.52 0.48
gi|122939198 Clathrin light chain A isoform c 7 0.44 0.45
gi|88014720 Importin subunit beta-1 9 0.41 0.42
gi|124486712 Ribosome-binding protein 1 isoform a 20 0.60 0.65
Regulation of apoptosis and cell death
gi|226874906 14-3-3 protein epsilon 13 2.01 1.62
gi|6756041 14-3-3 protein zeta/delta isoform 1 15 2.55 2.61
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Table 1 Modulated proteins (p <0.05) in PG-3T3L1 cells classified according to their principal biological process (Continued)
gi|6678682 Galectin-1 31 0.70 0.59
gi|329755243 Gelsolin isoform 2 22 1.85 1.89
gi|165932375 Plasminogen activator-inhibitor 1 RNA-binding
protein
31 0.67 0.68
gi|9790259 Programmed cell death protein 5 8 0.49 0.35
gi|6755963 Voltage-dependent anion-selective channel protein
1
15 2.53 2.41
Regulation of canonical Wnt signalling
gi|6679641 Emerin 8 2.87 3.42
gi|7305075 ras GTPase-activating protein-binding protein 1 16 2.25 1.99
gi|158854016 S-phase kinase-associated protein 1 7 0.50 0.50
Regulation of cell proliferation
gi|124517663 Annexin A1 28 2.44 1.88
gi|110625813 Astrocyte-derived neurotrophic factor precursor 11 0.47 0.47
gi|28461294 Protein CDV3 isoform b 8 0.52 0.57
gi|356640163 Serine hydroxymethyltransferase, mitochondrial 17 1.90 1.72
gi|6678483 Ubiquitin-like modifier-activating enzyme 1 15 0.59 0.58
Transcription
gi|188497724 Hepatoma-derived growth factor 12 0.55 0.50
gi|84875537 Nucleolin 33 3.60 4.17
gi|6679567 Polymerase I and transcript release factor 17 2.23 2.65
gi|13386026 UPF0568 protein C14orf166 homolog 9 0.60 0.60
Translation and ribosome assembly
gi|309266241 60S ribosomal protein L29-like 4 1.90 1.90
gi|309263511 60S ribosomal protein L32-like 6 7.27 9.17
gi|21426889 40S ribosomal protein S11 11 2.99 2.84
gi|13386034 40S ribosomal protein S13 10 4.74 6.81
gi|6677799 40S ribosomal protein S15 11 2.26 1.82
gi|12963511 40S ribosomal protein S19 10 2.92 3.02
gi|18087805 40S ribosomal protein S2 14 2.75 2.88
gi|13195604 40S ribosomal protein S23 7 5.35 4.83
gi|6755372 40S ribosomal protein S3 16 1.64 1.65
gi|254553321 40S ribosomal protein S3a 13 2.75 2.65
gi|6677805 40S ribosomal protein S4, X isoform 14 7.60 4.25
gi|6677813 40S ribosomal protein S8 12 5.30 5.39
gi|33504483 40S ribosomal protein S9 11 4.41 4.01
gi|6671569 60S acidic ribosomal protein P0 10 1.40 1.56
gi|83745120 60S acidic ribosomal protein P2 14 0.31 0.30
gi|16418339 60S ribosomal protein L10 11 3.04 3.81
gi|31981945 60S ribosomal protein L13a 9 3.96 3.00
gi|13385036 60S ribosomal protein L15 7 4.40 3.52
gi|83699424 60S ribosomal protein L18 5 3.03 3.22
gi|58037465 60S ribosomal protein L18a 6 2.99 2.92
gi|226958657 60S ribosomal protein L19 isoform 2 7 4.35 4.19
gi|18250296 60S ribosomal protein L24 6 4.45 4.11
gi|6677777 60S ribosomal protein L26 7 3.80 3.31
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Table 1 Modulated proteins (p <0.05) in PG-3T3L1 cells classified according to their principal biological process (Continued)
gi|8567400 60S ribosomal protein L27 9 5.65 5.99
gi|255308899 60S ribosomal protein L3 20 3.47 3.23
gi|94386224 60S ribosomal protein L36-like 4 9.03 8.15
gi|30794450 60S ribosomal protein L4 20 5.75 5.20
gi|23956082 60S ribosomal protein L5 10 2.04 1.32
gi|84662736 60S ribosomal protein L6 11 7.24 8.24
gi|31981515 60S ribosomal protein L7 9 5.65 6.23
gi|7305443 60S ribosomal protein L7a 9 6.30 6.42
gi|6755358 60S ribosomal protein L8 7 8.87 6.51
gi|14149647 60S ribosomal protein L9 9 1.81 2.29
gi|254540168 78 kDa glucose-regulated protein precursor 49 5.20 4.12
gi|82617575 Bifunctional glutamate/proline–tRNA ligase 6 0.43 0.44
gi|126032329 Elongation factor 1-alpha 1 33 2.48 2.63
gi|31980922 Elongation factor 1-beta 16 0.39 0.30
gi|33859482 Elongation factor 2 44 0.32 0.50
gi|21450625 Eukaryotic initiation factor 4A-I isoform 1 23 2.29 1.96
gi|146219837 Eukaryotic translation initiation factor 3 19 0.50 0.63
gi|365906249 Eukaryotic translation initiation factor 3 8 0.49 0.32
gi|167234372 Eukaryotic translation initiation factor 4B 23 0.59 0.60
gi|31712036 Eukaryotic translation initiation factor 5A-1 26 0.53 0.54
gi|94367038 40S ribosomal protein S6-like isoform 2 6 5.49 5.50
gi|309264022 40S ribosomal protein SA-like 16 3.02 4.32
gi|149251177 60S ribosomal protein L13-like 8 4.11 3.18
gi|377837258 60S ribosomal protein L23-like 8 3.83 3.84
gi|63572172 60S ribosomal protein L27a-like 4 6.99 5.21
gi|37497112 Putative RNA-binding protein 3 isoform 1 8 0.59 0.55
gi|31982373 rRNA 2′-O-methyltransferase fibrillarin 8 2.15 2.07
iTRAQ isobaric tags for relative quantification, PG progerin
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proteins presenting similar significant ratios in both iTRAQ
experiments 1 and 2 were considered modulated. The de-
tailed list of modulated proteins classified by principal bio-
logical process is presented in Table 1.
The list of modulated proteins was used to unravel, by
String 9.0 analysis, the molecular pathways altered in PG-
3T3L1 cells (Fig. 2c). Among the most important processes
determined are those related to translation (gene ontology
(GO) process: 0006412), ribosome biogenesis (GO process:
0042273) and protein folding (GO process: 0006457), but
also metabolism (GO process: 0008152), energy generation
by the mitochondria (GO process: 0006754) and structure
of the actin cytoskeleton (GO process: 0030036).Immunoblotting and real-time PCR validation of selected
modulated proteins
Orthogonal validation of iTRAQ results by western blot-
ting (Fig. 3) demonstrated in the first place that LaminA (ratio PG/control = 4.69) is actually accumulated in
PG-3T3L1. Besides, immunoblotting of NCL and cal-
nexin, both accumulated in PG-3T3L1, show similar
densitometry ratios (4.40 and 2.60) to those obtained by
iTRAQ quantification (3.83 and 1.84, respectively). Fi-
nally, cytochrome c is decreased in PG-3T3L1 cells
with a similar densitometry ratio (0.41) to that ob-
tained by iTRAQ quantification (0.43). Real-time PCR
data are in concordance with the proteomics data, with
the exception of cytochrome c. This gene is overexpressed
in PG-3T3L1 cells when compared with control.Study of the mitochondrial function in PG-3T3L1 cells
Since iTRAQ data suggest a dysfunction of the mito-
chondrial activity and a disorganization of the nuclear–
mitochondrial cytoskeleton network we decided to
determine the integrity of the mitochondrial network in
PG-3T3L1 cells. First spectrophotometric analysis of the
mitochondrial respiratory chain demonstrates significant
Fig. 3 Immunoblotting and RT-PCR verification of selected proteins. a Western blotting analysis confirms the modulation of Lamin A, calnexin
(CALX), nucleolin (NCL), and cytochrome c (CYC). Loading of equal amount of total protein was tested by Ponceau red staining (not shown) and
α-tubulin immunoblotting. b Real-time PCR analysis of the selected proteins normalized against Hprt gene levels. *Significance (p <0.05) using the
Kruskal–Wallis non-parametric test. **Significance (p <0.01) using the Kruskal–Wallis non-parametric test. iTRAQ isobaric tags for relative quantification,
PG progerin
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and V (Fig. 4a). The mitochondrial superoxide anion was
determined by flow-cytometry measurement of MitoSox™-
treated cells, revealing that PG-expressing cells show a
significant (p <0.05) increase in superoxide anion produc-
tion (Fig. 4b). Furthermore, the OCR, a parameter that is
proportional to mitochondrial basal activity, is also signifi-
cantly (p <0.001) increased in PG-3T3L1 cells (Fig. 4c).
Reduction of ROS levels with ROS scavengers and the
effect of autophagy
Incubation of PG-3T3L1 with a general ROS scavenger
(N-acetyl-cysteine (NAC) 10 mM for 1 hour; Fig. 5a, b)
or a superoxide-specific quencher (MitoTempo 10 μM
for 1 hour; Fig. 5c, d) results in a significant (p <0.05)
reduction of the autophagic marker LC3-II/LC3-I ratio,
indicating a decrease in autophagic proteolysis.
Discussion
Aging is defined as the accumulation of diverse deleterious
changes occurring in cells and tissues with advancing age
that are responsible for the increased risk of disease and
death [30]. Aging is now considered to be a very complex,
multi-factorial process [31]. Several aging theories have
been proposed, but to date no single theory explains all of
the major age-related physiological changes. Among those
theories, the role of mitochondrial dysfunction and free
radical accumulation in aging and disease has gained
strength in recent years [32–35], in part owing to thesatisfactory effects exerted by antioxidant compounds in
in-vitro studies [36] and therapy [37–39].
Premature aging syndromes are used as models to
understand molecular causes of aging-related changes.
Among these diseases, HGPS is one of the most studied,
although to date few proteomics studies have tried to deep
into the mechanisms triggered by the accumulation of the
causal agent (PG). Peinado et al. [40] demonstrated using
a differential in gel electrophoresis (DIGE) approach that
mitochondrial dysfunction and disorganization of the cyto-
skeleton were characteristic of the adipose tissue in
ZMPSTE24 null mice, which mimic some but not all of the
symptoms associated with HGPS-derived cells. Recently,
similar results have been found in HGPS cells [41] follow-
ing a stable isotopic labeling approach. To examine by
quantitative proteomics (iTRAQ) the effect of the impair-
ment of the expression of Lamin A, we used a lentiviral sys-
tem to efficiently deliver PG expression in 3T3L1 pre-
adipocytes. The efficient expression of PG in PG-transduced
3T3L1 cells was corroborated by immunoblotting (Fig. 1a).
These cells present a decrease in both proliferative capacity
and adipogenic potential (Fig. 1b, c), which is in agreement
with previous results [29]. Since GFP-3T3L1 cells are similar
to non-transduced 3T3L1 in terms of lamin expression, adi-
pogenic capacity and proliferative rate, we decided to use
that cell line as a control for the iTRAQ labelling and subse-
quent validations. A total of 1633 different proteins were
quantified, and 181 of them were significantly modulated in
PG-expressing cells versus control. To our knowledge, our
Fig. 4 Mitochondrial dysfunction and ROS overproduction in 3T3L1-PG cells. a Measurement of the mitochondrial complex activity in digitonin-
permeabilized cells demonstrates significant changes in complexes I, IV and V. b PG-3T3L1 cells show a significant increase in the mitochondrial
ROS production, as revealed by MitoSox™ analysis. c Measurement of the rate of oxygen consumption (OCR) indicates that PG-3T3L1 cells have
an increased mitochondrial basal activity. *Significance (p <0.05) using the Kruskal–Wallis non-parametric test. ***Significance (p <0.001) using the
Kruskal–Wallis non-parametric test. Scale bar = 10 μm. CS citrate synthase, PG progerin
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on the effect of PG expression to date.Quantitative proteomics data suggest massive modulation
of cytoskeleton organization, cell proliferation and protein
synthesis processes
String 9.0 analysis demonstrate that expression of PG
in 3T3L1 cells promotes changes in protein translation, en-
ergy generation by mitochondria, protein folding,
response to stress, lipid metabolism and cytoskeleton
organization.
Expression of PG in 3T3L1 cells promotes modulation
of a large set of regulators and structural components of
the cytoskeleton, mainly those involved in the proper
maintenance of the filamentous network connecting
nucleus, endoplasmic reticulum and mitochondria. Of
special interest we have detected upregulation of vimentin
(ratio PG/control = 27.28) and cytoskeleton-associated pro-
tein 4 (ratio PG/control = 5.9), and downregulation of fila-
mins A (ratio PG/control = 0.06), B (ratio PG/control = 0.18)
and C (ratio PG/control = 0.43). Modulation of vimentin hasbeen described previously in Zmpste24−/− mice [40] and
HGPS-derived cell lines [41].
Calcium ions are signalling molecules in living cells
and play essential roles in cellular processes such as cell
proliferation, enzyme activity, muscle contraction, cellu-
lar motility, maintenance of the structural integrity of
the cytoskeleton and membrane transport, among others
[42]. Our proteomics data show modulation of a set of
proteins involved in calcium-mediated signalling, includ-
ing calmodulin (ratio PG/control = 0.31), caldesmon 1 (ra-
tio PG/control = 2.29), calnexin (ratio PG/control = 1.83)
and calreticulin ratio (PG/control = 3.73). Of special inter-
est, calnexin is part of the quality control machinery that
holds back improperly folded proteins in the endoplasmic
reticulum [43]. Western blot and real-time PCR validation
(Fig. 3) confirms the increase of calnexin in PG-3T3L1
cells, suggesting that protein misfolding is enhanced by
PG expression, a phenomenon described previously in
biological [44, 45] and PG-related [46] aging.
It is now widely accepted that PG accumulation
modulates molecular pathways such as mTOR, pRB
and Wnt signalling cascades, driving alterations in the
A B
C D
Fig. 5 Effect of ROS scavengers on the autophagic proteolysis in PG-3T3L1 cells. a, b Western blot analysis of LC3 demonstrates a significant reduction
in the LC3-II/LC3-I ratio in PG-3T3L1 cells incubated with 10 mM N-acetyl-cysteine (NAC) for 1 hour when compared with basal conditions. c, d
Western-blot analysis of LC3 demonstrates a significant reduction in the LC3-II/LC3-I ratio in PG-3T3L1 cells incubated with 10 μM MitoTempo for 1 hour
when compared with basal conditions. LC3 light chain 3, PG progerin
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proliferation [8, 9, 47]. In our model we have detected
modulation of proteins belonging to those three pro-
cesses. For instance, voltage-dependent anion-selective
channel protein 1, involved in the formation of apop-
totic pores in the mitochondria [48], is upregulated in
PG-3T3L1 cells (ratio PG/control = 2.53), as well as
emerin (ratio PG/control = 3.31). This protein interacts
with LAP2α and links nuclear Lamin A and actin cytoskel-
eton, negatively modulating accumulation of beta-catenin
in the nucleus [49, 50].
Proteomic data strongly suggest a massive modulation
of all molecular processes that culminate in protein syn-
thesis and function. Of special interest is the modulation
detected on NCL, the major component of the nucleolus
and a repressor of the transcription [51]. This protein is
upregulated in PG-expressing 3T3L1 cells (ratio PG/
control = 3.84). Western blot validation confirms the
quantitative proteomics result, as well as real-time PCR
analysis. Interestingly, NCL associates with chromatin
and is a nucleolar marker of several pathological condi-
tions, ranging from cancer to autoimmune diseases [52].
Protein SET, which mediates histone acetylation and nu-
cleosome assembly, appears dramatically decreased in
PG-expressing cells (ratio PG/control = 0.24). Also, a
large set of structural ribosomal proteins and transla-
tion initiation factors appear to be modulated in ourproteomic screening, in agreement with previous data
from Rivera-Torres et al. [41], indicating that PG expres-
sion exerts a dramatic alteration in protein synthesis and
function.
Quantitative proteomic data suggest that PG delivery
induces defects on de-novo lipid synthesis and energy
storage. Three main proteins are decreased in PG-3T3L1
cells. ATP-citrate synthase (ratio PG/control =0.49), fatty
acid synthase (ratio PG/control = 0.55) and acyl-CoA-
binding protein (ratio PG/control =0.29). All of them are
part of the cellular machinery responsible for the con-
densation of acetyl CoA and malonyl CoA and the for-
mation of medium and long-chain fatty acids and
triacylglycerides that are the main energy repository in
the cells [53]. Furthermore, inhibition of ATP-citrate
synthase has been recently linked to a decrease in prolif-
eration rate [54], which has been detected in our model
(Fig. 1) and is a typical characteristic of PG-expressing
cells. Our data agree with previous results from other
PG-expression models [28, 40].Mitochondrial dysfunction and imbalance in stress
response are linked to loss of proteostasis and increase of
autophagy in progerin-expressing cells
Since energy storage and lipogenesis are modulated in our
model of PG overexpression, it is plausible, a priori, to
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dation–reduction processes could be also affected. iTRAQ
analysis demonstrated modulation of several components
of the mitochondrial respiratory chain, especially complex
IV and complex V. The complex III–complex IV electron
carrier cytochrome c (ratio PG/control = 0.43) and the
complex IV component cytochrome c oxidase (ratio PG/
control = 0.32) are significantly decreased in PG-3T3L1
cells. Cytochrome c decrease has been validated by im-
munoblotting (Fig. 3) and is in agreement with previous re-
sults [41]. However, real-time PCR analysis of cytochrome
c shows an increase in the expression of this gene in PG-
3T3L1 cells.
We asked whether this modulation of several compo-
nents of the mitochondrial respiratory chain detected in
PG-3T3L1 cells by quantitative proteomics drives uncoup-
ling of the electron transport chain. Measurement of the
MRC complex activities demonstrates significant differ-
ences in the activity of complex IV and V, which agrees
with previous results [41], but also complex I (Fig. 5a). The
activity of this complex is twice as high in PG-3T3L1 when
compared with control. Complex I is the main contributor
for the generation of mitochondrial ROS and specifically
the superoxide anion [55, 56], which has been proposed as
one of the factors responsible for several mitochondrial
pathologies [57] and plays a central role in the free rad-
ical theory of aging [31]. We have found a significantlyFig. 6 Model representing the main cellular events triggered by lentiviral-d
aging. PG accumulation leads to modulation of mTOR and WnT pathways, alt
and reactive oxygen species (ROS) overproduction, ultimately contributing tooverproduction of mitochondrial superoxide produc-
tion in PG-3T3L1 cells, as revealed by MitoSox meas-
urement (Fig. 4b).
Heat shock proteins (hsp) and chaperones are responsible
for monitoring the quality of the proteins, to maintain the
homeostasis of the proteome (proteostasis) and to derive
incorrect isoforms for ATP-dependent degradation by the
proteasome, and are upregulated in living cells in response
to environmental stress conditions. We have found a dra-
matic increase of this group of proteins in PG-3T3L1 cells,
indicating an activation of chaperone-mediated autophagy
(CMA), a process recently described in age-related patholo-
gies [58, 59]. The most obvious examples are hsp60 (ratio
PG/control = 18.53), heat shock cognate 71 kDa protein
(ratio PG/control =16.59) and endoplasmin or GRP94 (ratio
PG/control =6.91). Hsp60 is one of the central components
that regulate proteostasis during redox imbalance [60], and
is upregulated in stress and disease. Heat shock cognate
71 kDa protein acts as a repressor at the transcriptional
level [61]. Finally, GRP94 is a marker of endoplasmic
reticulum-mediated degradation of proteins and has been
recently involved in regulation of the canonical Wnt signal-
ling pathway [62]. The loss of proteostasis could explain
the apparent discordance between the proteomics and gen-
omics data for cytochrome c. The elevated levels of mito-
chondrial ROS could promote an increase in the misfolding
of the components of the respiratory chain, driving anriven PG nuclear accumulation and their contribution to the premature
eration in the protein synthesis machinery and mitochondrial dysfunction
the premature aging phenotype
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investigation is necessary to demonstrate this hypothesis.
Previously, an increase in autophagic proteolysis has been
reported in the progeroid phenotype [63, 64], suggesting
that chronic activation of an, a priori, pro-survival cellular
mechanism can turn into a harmful and detrimental
process. We therefore asked whether a reduction of ROS
cellular levels could promote a modulation of this process.
Incubation of the PG-3T3L1 cells with a general ROS scav-
enger (NAC 10 mM) or a superoxide anion-specific scaven-
ger (MitoTempo 10 μM) exerts a significant (p <0.05)
reduction of the LC3-II/LC3-I ratio (Fig. 5), pointing to a
reduction in the autophagic proteolysis in accordance with
the growing evidence supporting the key role of ROS in the
aging process.
Conclusions
Our study represents one further step in the achievement
of understanding the aging process. With our results, but
also taking into account the results of excellent studies
made by other research groups in recent years, we have
tried to build a global scheme with a compilation of the
main cellular events that leads to premature aging in HGPS
driven by PG accumulation (Fig. 6). In the present work,
we have demonstrated that PG expression promotes mito-
chondrial dysfunction and ROS overproduction. These
events are, at least in part, the cause of an increase in pro-
tein misfolding and autophagic proteolysis leading, ultim-
ately, to a global loss of proteostasis that partially
contributes to the premature aging process. We have also
demonstrated that treatment of the cells with antioxidant
compounds reduces the autophagic phenotype, thus sup-
porting the growing evidence indicating the importance of
this kind of compound as candidates for therapeutics in
aging-related diseases.
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